Nakamuta M - Search Results

1

A new parameter using serum lactate dehydrogenase and alanine aminotransferase level is useful for predicting the prognosis of patients at an early stage of acute liver injury: a retrospective study.

Kotoh K, Enjoji M, Kato M, Kohjima M, Nakamuta M, Takayanagi R. Kotoh K, et al. Among authors: nakamuta m. Comp Hepatol. 2008 Aug 14;7:6. doi: 10.1186/1476-5926-7-6. Comp Hepatol. 2008. PMID: 18700988 Free PMC article.

2

Anti-tolA antibody in non-A, non-B chronic liver disease.

Nakamuta M, Sugimura T, Kotoh K, Fukutomi T, Sakamoto S, Yamamoto M, Nawata H. Nakamuta M, et al. Fukuoka Igaku Zasshi. 1992 Oct;83(10):367-76. Fukuoka Igaku Zasshi. 1992. PMID: 1281459

3

Molecular cloning, sequence analysis and expression of a cDNA encoding human type-1 angiotensin II receptor.

Takayanagi R, Ohnaka K, Sakai Y, Nakao R, Yanase T, Haji M, Inagami T, Furuta H, Gou DF, Nakamuta M, et al. Takayanagi R, et al. Among authors: nakamuta m. Biochem Biophys Res Commun. 1992 Mar 16;183(2):910-6. doi: 10.1016/0006-291x(92)90570-b. Biochem Biophys Res Commun. 1992. PMID: 1550596

4

Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptor.

Nakamuta M, Takayanagi R, Sakai Y, Sakamoto S, Hagiwara H, Mizuno T, Saito Y, Hirose S, Yamamoto M, Nawata H. Nakamuta M, et al. Biochem Biophys Res Commun. 1991 May 31;177(1):34-9. doi: 10.1016/0006-291x(91)91944-8. Biochem Biophys Res Commun. 1991. PMID: 1710450

5

Soluble Arg-Gly-Asp peptides reduce collagen accumulation in cultured rat hepatic stellate cells.

Iwamoto H, Sakai H, Kotoh K, Nakamuta M, Nawata H. Iwamoto H, et al. Among authors: nakamuta m. Dig Dis Sci. 1999 May;44(5):1038-45. doi: 10.1023/a:1026633302985. Dig Dis Sci. 1999. PMID: 10235616

6

Role of Rho small GTP binding protein in the regulation of actin cytoskeleton in hepatic stellate cells.

Kato M, Iwamoto H, Higashi N, Sugimoto R, Uchimura K, Tada S, Sakai H, Nakamuta M, Nawata H. Kato M, et al. Among authors: nakamuta m. J Hepatol. 1999 Jul;31(1):91-9. doi: 10.1016/s0168-8278(99)80168-8. J Hepatol. 1999. PMID: 10424288

7

Serum level of interleukin-4 is a possible marker of therapeutic response to interferon treatment in patients with chronic hepatitis C.

Higashi N, Nakamuta M, Motomura K, Enjoji M, Sakai H, Nawata H. Higashi N, et al. Among authors: nakamuta m. J Hepatol. 1999 Aug;31(2):383. doi: 10.1016/s0168-8278(99)80242-6. J Hepatol. 1999. PMID: 10453958 Clinical Trial. No abstract available.

8

Self-regulation of type I collagen degradation by collagen-induced production of matrix metalloproteinase-1 on cholangiocarcinoma and hepatocellular carcinoma cells.

Enjoji M, Kotoh K, Iwamoto H, Nakamuta M, Nawata H. Enjoji M, et al. Among authors: nakamuta m. In Vitro Cell Dev Biol Anim. 2000 Feb;36(2):71-3. doi: 10.1290/1071-2690(2000)036<0071:SROTIC>2.0.CO;2. In Vitro Cell Dev Biol Anim. 2000. PMID: 10718360 No abstract available.

9

Transforming growth factor-alpha induces the differentiation of sarcomatoid cholangiocarcinoma cells.

Enjoji M, Nakashima M, Nakamuta M, Nawata H. Enjoji M, et al. Among authors: nakamuta m. Jpn J Cancer Res. 2000 Feb;91(2):223-30. doi: 10.1111/j.1349-7006.2000.tb00935.x. Jpn J Cancer Res. 2000. PMID: 10761710 Free PMC article.

10

Platelet-derived growth factor receptor tyrosine kinase inhibitor AG1295 attenuates rat hepatic stellate cell growth.

Iwamoto H, Nakamuta M, Tada S, Sugimoto R, Enjoji M, Nawata H. Iwamoto H, et al. Among authors: nakamuta m. J Lab Clin Med. 2000 May;135(5):406-12. doi: 10.1067/mlc.2000.105974. J Lab Clin Med. 2000. PMID: 10811056

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters